Intra-Cellular Therapies, Inc. (ITI) Company Profile

19:43 EDT 23rd June 2018 | BioPortfolio

Intra-Cellular Therapies, Inc. (ITI) is a biotechnology company developing novel therapeutics for the treatment of depression, schizophrenia, Alzheimer's and Parkinson's disease and other disorders of the Central Nervous System. Using IntraPath, its broad technology platform, ITI has identified nerve-signaling proteins, validated their roles in vivo and is currently using these proteins as targets for small molecule drugs. Commercializing the Nobel-prize winning research of Dr. Paul Greengard, ITI is uniquely positioned to develop novel therapies for neuropsychiatric and neurodegenerative disorders. With its broad expertise in the molecular basis of neurotransmitter and drug action, ITI is validating drug candidates for its internal drug discovery programs and for its pharmaceutical partners. Founded by Drs. Greengard, Sharon Mates and Allen Fienberg, ITI began operations in May 2002 and is headquartered in the Audubon Biomedical Science & Technology Park in New York City.


3960 Broadway
New York
New York
United States of America


Phone: 212.923.3344
Fax: 212.923.3388

News Articles [593 Associated News Articles listed on BioPortfolio]

Intra-Cellular Therapies Initiates Rolling Submission of New Drug Application for Lumateperone for Treatment of Schizophrenia

NEW YORK, June 06, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disord...

Intra-Cellular gets positive FDA feedback on rolling NDA for schizophrenia drug

The FDA and Intra-Cellular Therapies have reached an agreement on the proposed content and timing of a rolling new drug appli -More- 

Investor Network: Intra-Cellular Therapies, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 1, 2018 / Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) will be discussing their earnings results in their Q4 Earnings Call to be held on March 1, 2018, at 8:30 AM...

Intra-Cellular Therapies' (ITCI) CEO Sharon Mates on Q4 2017 Results - Earnings Call Transcript

3 Things In Biotech, May 7: Novartis Thyroid Breakout, Redhill's Stomach Bugs, Intra-Cellular Update On Schizoid Drugs

Exploring determinants predicting response to intra-articular hyaluronic acid treatment in symptomatic knee osteoarthritis: 9-year follow-up data from the Osteoarthritis Initiative

The weight of recommendation for intra-articular therapies such as hyaluronic acid injections varies from one set of guidelines to another, and they have not yet reached unanimity with respect to the ...

Cellular valve structure opens up potential novel therapies

(University of Zurich) Biochemists at the University of Zurich have determined the detailed structure of a volume-regulated chloride channel. This cellular valve is activated in response to swelling t...

Stem Cell Firm Cellular Dynamics to Provide Heart Cells to Takeda

 Fujifilm said it plans to use stem cells developed by Cellular Dynamics International, a Wisconsin-based company it owns, as part of a new partnership between Fujifilm and Takeda Pharmaceutical that...

PubMed Articles [2225 Associated PubMed Articles listed on BioPortfolio]

Cellular Therapies in Orthopedics: Where Are We?

The orthopedic field has experienced several major practice-changing pivotal shifts in the past several decades, such as the invention and application of the arthroscope or the implementation and adva...

Intra- and Intercellular Quality Control Mechanisms of Mitochondria.

Mitochondria function to generate ATP and also play important roles in cellular homeostasis, signaling, apoptosis, autophagy, and metabolism. The loss of mitochondrial function results in cell death a...

Clinical Relevance of Intra-Tumour Heterogeneity.

Fairness in Manufacturing Cellular Therapies.

Regional therapies for locoregionally advanced and unresectable melanoma.

Locoregionally advanced and unresectable disease can be seen in up to 10% of melanoma patients. Treatment options for these patients have been evolving most notably over the past few decades and have ...

Clinical Trials [3376 Associated Clinical Trials listed on BioPortfolio]

Regenerative Cellular Therapies, Physiology, Pathology and Developmental Biology

This study aims to use tissue from deceased organ donors to investigate organ physiology, developmental biology, as well as the development of future regenerative cellular therapies. It wi...

Cellular Adoptive Immunotherapy in Treating Patients With Glioblastoma Multiforme

RATIONALE: Biological therapies, such as cellular adoptive immunotherapy, may stimulate the immune system in different ways and stop tumor cells from growing. Aldesleukin may stimulate the...

Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer

RATIONALE: Biological therapies, such as cellular adoptive immunotherapy, stimulate the immune system in different ways and stop tumor cells from growing. PURPOSE: This phase I trial is s...

Impact of Omega-3 Fatty Acids on Lactate

Pre- and intra-operative nutritional support in patient undergoing major surgery results in decreased morbidity and mortality. Studies investigating the role of omega-3 fatty acids in thes...

Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC)

Dendritic cell-based cellular vaccine for tumor therapy has shown efficacy. This study is designed to perform a personalized clinical trial by first analyzing the expression of tumor assoc...

Companies [1196 Associated Companies listed on BioPortfolio]

Intra-Cellular Therapies, Inc.

Intra-Cellular Therapies, Inc. (ITI)

Intra-Cellular Therapies, Inc. (ITI) is a biotechnology company developing novel therapeutics for the treatment of depression, schizophrenia, Alzheimer's and Parkinson's disease and other disorders of...


Philadelphia-based Intracorp, a subsidiary of CIGNA Corporation, helps employers maximize their workers' compensation and disability benefits programs to enhance the well-being an...

Intra-Lock® International, Inc.

Intra-Lock® International Inc., headquartered in Boca Raton, Florida, USA, is a leading provider of innovative dental restoration solutions including a wide range of dental imp...

Aastrom Biosciences, Inc.

Founded in 1989 and with headquarters in Ann Arbor, Michigan, Aastrom Biosciences is dedicated to the development of stem cell treatments for critical cardiovascular diseases. Aastrom is currently e...

More Information about "Intra-Cellular Therapies, Inc. (ITI)" on BioPortfolio

We have published hundreds of Intra-Cellular Therapies, Inc. (ITI) news stories on BioPortfolio along with dozens of Intra-Cellular Therapies, Inc. (ITI) Clinical Trials and PubMed Articles about Intra-Cellular Therapies, Inc. (ITI) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Intra-Cellular Therapies, Inc. (ITI) Companies in our database. You can also find out about relevant Intra-Cellular Therapies, Inc. (ITI) Drugs and Medications on this site too.

Quick Search


Relevant Topics

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Bipolar Disorders
Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks. Over half of Bipolar cases develops before the age of 25. Bipolar ...

Corporate Database Quicklinks

Searches Linking to this Company Record